Arthritis & Rheumatism

Xeljanz approved for rheumatoid arthritis

(HealthDay)—Xeljanz (tofacitinib) has been approved by the U.S. Food and Drug Administration to treat symptoms of rheumatoid arthritis (RA) among people who can't tolerate, or haven't been helped by, the drug methotrexate.

Arthritis & Rheumatism

Ultrasound model IDs residual joint inflammation in RA

(HealthDay)—A model including ultrasound (US) assessment of the wrist, metacarpophalangeal (MCP), ankle, and metatarsophalangeal (MTP) joints is highly sensitive for detecting B-mode and Doppler joint inflammation in patients ...

Diseases, Conditions, Syndromes

Studies explore racial disparities in IBD symptoms and therapy

Three separate studies presented today at the American College of Gastroenterology's (ACG) 77th Annual Scientific meeting in Las Vegas help to advance understanding of the differences between African American and Caucasian ...

Diseases, Conditions, Syndromes

Scientists step up hunt for bacterial genes tied to Lyme disease

Investigators at The University of Texas Health Science Center at Houston (UTHealth) have accelerated the search for the bacterial genes that make the Lyme disease bacterium so invasive and persistent. The discovery could ...

Arthritis & Rheumatism

Rheumatoid arthritis: Biologics in second-line therapy show benefit

The German Institute for Quality and Efficiency in Health Care (IQWiG) examined 9 biotechnologically produced drugs for the treatment of adults with rheumatoid arthritis in whom prior pharmacological treatment had failed. ...

page 5 from 7